1. Home
  2. IMRN vs HTCR Comparison

IMRN vs HTCR Comparison

Compare IMRN & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.81

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$0.22

Market Cap

6.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRN
HTCR
Founded
1994
2009
Country
Australia
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.5M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
IMRN
HTCR
Price
$0.81
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.3K
162.6K
Earning Date
02-25-2026
05-14-2026
Dividend Yield
N/A
57.47%
EPS Growth
N/A
66.67
EPS
N/A
N/A
Revenue
N/A
$30,407,229.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.19
52 Week Low
$0.68
$0.22
52 Week High
$2.38
$1.66

Technical Indicators

Market Signals
Indicator
IMRN
HTCR
Relative Strength Index (RSI) 47.58 39.12
Support Level $0.69 $0.22
Resistance Level $0.89 $0.26
Average True Range (ATR) 0.05 0.02
MACD 0.01 -0.00
Stochastic Oscillator 30.93 7.13

Price Performance

Historical Comparison
IMRN
HTCR

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: